Personalised & optimised therapy (POT) algorithm using five cognitive and behavioural skills for subthreshold depression
The protocol paper16 and the primary analysis paper17 provide detailed information about the RESiLIENT trial (UMIN Clinical Trials Registry UMIN000047124, registered on 1 August 2022). The study was approved by
Revolutionize Fundraising in Switzerland: Happy Pot GmbH Launches Online Platform – AZCentral | The Arizona Republic
Happy Pot GmbH has just introduced a new fundraising platform in Switzerland. This innovative tool is set to help schools, non-profits, and community groups raise money without needing to pay